Cheryl R. Blanchard - 15 Jun 2021 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
President, CEO, Director, Director
Signature
/s/ Cheryl R. Blanchard
Issuer symbol
ANIK
Transactions as of
15 Jun 2021
Net transactions value
+$100,000
Form type
4
Filing time
17 Jun 2021, 16:31:11 UTC
Next filing
24 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Options Exercise $100,000 +2,994 +8.7% $33.40 37,472 15 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIK Stock Option (Right to Buy) Options Exercise $0 -2,994 -2.9% $0.000000 101,644 15 Jun 2021 Common Stock 2,994 $33.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest in three equal annual installments beginning on April 26, 2021.